Bahman Anvari

Title: Innovations of Bahman Anvari in Phototherapy

Introduction

Bahman Anvari is an accomplished inventor based in Tustin, California. He has made significant contributions to the field of phototherapy through his innovative research and development of novel methods and compositions. His work focuses on the synthesis of nanoparticle-assembled microcapsules, which serve as delivery vehicles for photosensitive compounds.

Latest Patents

Anvari holds a patent for "Charge-assembled capsules for phototherapy." This patent describes a groundbreaking approach to phototherapeutic methods. The synthesis of these microcapsules occurs through a two-step assembly process, combining charged polymer chains and counterions with a photosensitive compound. The resulting photosensitive aggregates are then combined with nanoparticles to form the microcapsules. The shell of these microcapsules can be composed of nanoparticles and/or polymer, while the core contains the photosensitive compound. This rapid formation process occurs under mild conditions, making it highly suitable for encapsulating charged photosensitive molecules like ICG. Anvari's patent is a testament to his innovative approach in the field.

Career Highlights

Bahman Anvari is affiliated with William Marsh Rice University, where he continues to advance his research in phototherapy. His work has garnered attention for its potential applications in medical treatments and therapies. With a focus on developing effective delivery systems for photosensitive compounds, Anvari's contributions are paving the way for future innovations in the field.

Collaborations

Anvari has collaborated with notable colleagues, including Michael Sha-nang Wong and Mohammad Abbas Yaseen. These collaborations have further enriched his research and expanded the impact of his work in phototherapy.

Conclusion

Bahman Anvari's innovative work in phototherapy, particularly through his patented microcapsule technology, showcases his dedication to advancing medical science. His contributions are significant and hold promise for future therapeutic applications.